financetom
Business
financetom
/
Business
/
PTC forecasts quarterly revenue below estimates on tight tech spending
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
PTC forecasts quarterly revenue below estimates on tight tech spending
Nov 9, 2024 11:47 AM

Nov 6 (Reuters) - Industrial software maker PTC

forecast first-quarter revenue below estimates on Wednesday,

signaling continued weakness in demand for its industrial design

and testing software as companies keep a tight leash on budgets.

Businesses have dialed back on software budgets in the wake

of high-interest rates and an uncertain economy, weighing on

demand for companies such as PTC.

With companies like Volkswagen and Indian

motorcycle maker Eicher Motors' Royal Enfield as

clients, PTC makes software that helps firms design, build and

manage products throughout their life cycles.

The Boston-based company also said that its board has

authorized a share repurchase of up to $2 billion through

September 2027.

The company expects revenue to be between $540 million and

$570 million in the first quarter, below analysts' average

estimate of $609.1 million, according to data complied by LSEG.

PTC projected adjusted earnings per share of 75 cents to 95

cents for the quarter, compared with analysts' estimate of

$1.33.

For the fiscal year 2025, PTC expects revenue to be between

$2.51 billion and $2.61 billion, the midpoint of which is above

analysts' average estimate of $2.54 billion.

It posted revenue of $626.5 million for the fourth quarter

ended Sept. 30, compared with the average analyst estimates of

$620.5 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Aurinia Pharmaceuticals Reportedly Files Lawsuit Against US FDA Official
Aurinia Pharmaceuticals Reportedly Files Lawsuit Against US FDA Official
Nov 3, 2025
11:00 AM EST, 11/03/2025 (MT Newswires) -- Aurinia Pharmaceuticals ( AUPH ) has filed a lawsuit against US Food and Drug Administration drug division chief George Tidmarsh, accusing Tidmarsh of defaming one of its drugs, among other allegations, according to media reports Sunday. Tidmarsh has resigned from his position at the FDA, the media reports said. Aurinia filed the lawsuit...
Crane Harbor Acquisition Signs Deal to Combine With Xanadu Quantum Technologies
Crane Harbor Acquisition Signs Deal to Combine With Xanadu Quantum Technologies
Nov 3, 2025
11:00 AM EST, 11/03/2025 (MT Newswires) -- Crane Harbor Acquisition ( CHAC ) and photonic quantum computing company Xanadu Quantum Technologies said Monday that they have signed a definitive business combination agreement. The combined company will be valued at a pro forma enterprise value of about $3.1 billion, and will receive roughly $225 million from Crane Harbor's trust account, assuming...
Palantir's Q3 Results Likely to be Major Step in 'Right Direction' in AI Revolution, Wedbush Says
Palantir's Q3 Results Likely to be Major Step in 'Right Direction' in AI Revolution, Wedbush Says
Nov 3, 2025
11:42 AM EST, 11/03/2025 (MT Newswires) -- Palantir Technologies' ( PLTR ) Q3 earnings are likely to be another major step in the right direction of the artificial intelligence revolution, Wedbush said in a Sunday research report. The company is due to report Q3 results on Monday, following the close of US markets. The company could reach a trillion-dollar market...
AstraZeneca Shareholders Approve Harmonized Listing Structure
AstraZeneca Shareholders Approve Harmonized Listing Structure
Nov 3, 2025
11:42 AM EST, 11/03/2025 (MT Newswires) -- AstraZeneca ( AZN ) said Monday its shareholders approved a special resolution at a general meeting to adopt new articles of association, allowing the company to proceed with plans to harmonize its equity listing structure across London, Stockholm and New York. The resolution passed with 99.36% of votes cast in favor. AstraZeneca (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved